Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 1309225.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Many cancer cell lines express basic fibroblast growth factor (FGF) receptors, making them potential targets for the delivery of FGF-based cytotoxic compounds. To this end, we have investigated the antitumor activity of a novel mitotoxin, Fibroblast Growth Factor-saporin (FGF-SAP), a conjugate of FGF and the ribosome-inactivating protein, saporin. In vitro, FGF-SAP is cytotoxic for human melanoma, teratocarcinoma, and neuroblastoma cells expressing FGF-receptors. Mice treated with FGF-SAP i.v., on a variety of schedules, showed dramatic tumor growth inhibition with minimal toxicity. Thus, FGF-SAP appears to be a well-tolerated and potent antitumor agent. The potential of FGF-targeted cytotoxicity is discussed.
Medical subject headings
- Antineoplastic Agents, Phytogenic
- Fibroblast Growth Factor 2
- Immunotoxins
- Melanoma
- N-Glycosyl Hydrolases
- Neuroblastoma
- Ovarian Neoplasms
- Plant Proteins
- Teratoma